- SEK40.57bn
- SEK36.61bn
- SEK2.27bn
Europe Research Roundup: Aedifica, Montana Aerospace, Sodexo
Brief: Camurus Announces FDA Acceptance Of NDA Resubmission For Oclaiz
Brief: Camurus Says FDA Sets PDUFA Target Action Date For Oclaiz
Brief: Gubra And Camurus Enter Into Collaboration And License Agreement
Camurus jumps on positive topline result for its once-monthly GLP-1 candidate
Brief: Camurus Reports Positive Topline Results For CAM2056
Camurus falls after Q3 revenues miss, Kempen still sees "attractive" valuation
Brief: Camurus Q3 EBIT At SEK 230 Mln
Europe Research Roundup: Adidas, Boliden, LSEG
U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus
U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus
Camurus could see largest inflection point with tumor drug CAM2029, Van Lanschot Kempen says
Brief: Camurus Announces Approval Of Oczyesa For The Treatment Of Acromegaly In The UK
Brief: Camurus Announces Approval Of Oczyesa For Treatment Of Acromegaly In UK
Brief: Camurus Maintains Financial Outlook For 2025
Brief: Camurus' Oczyesa Receives Marketing Authorization In EU
Brief: Camurus' Oczyesa Receives Marketing Authorization For Treatment Of Acromegaly In The EU
Brief: Camurus' Oczyesa Receives Marketing Authorization For Treatment Of Acromegaly In The EU
Europe Research Roundup: Berkeley Group, Diageo, Yara